Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Desfesoterodine

🥰Excellent
Catalog No. T6364Cas No. 207679-81-0
Alias PNU-200577, 5-hydroxymethyl Tolterodine, 5-HMT, 5-HM, (R)-5-Hydroxymethyl Tolterodine

Desfesoterodine (5-HMT) is a new muscarinic receptor antagonist with Kb of 0.84 nM.

Desfesoterodine

Desfesoterodine

🥰Excellent
Purity: 100%
Catalog No. T6364Alias PNU-200577, 5-hydroxymethyl Tolterodine, 5-HMT, 5-HM, (R)-5-Hydroxymethyl TolterodineCas No. 207679-81-0
Desfesoterodine (5-HMT) is a new muscarinic receptor antagonist with Kb of 0.84 nM.
Pack SizePriceAvailabilityQuantity
1 mg$60In Stock
5 mg$147In Stock
10 mg$228In Stock
25 mg$392In Stock
50 mg$578In Stock
100 mg$833In Stock
500 mg$1,690In Stock
1 mL x 10 mM (in DMSO)$162In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Desfesoterodine"

Select Batch
Purity:100%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Desfesoterodine (5-HMT) is a new muscarinic receptor antagonist with Kb of 0.84 nM.
Targets&IC50
mAChR:0.84 nM(Kb)
In vitro
Desfesoterodine is a major pharmacologically active metabolite of tolterodine. Desfesoterodine produces a competitive and concentration-dependent inhibition of carbachol-induced contraction of guinea-pig isolated urinary bladder strips. Desfesoterodine antagotizes muscarinic receptors with a pA2 of 9.1. Desfesoterodine causes a concentration-dependent inhibition of (-)3 H-QNB binding in homogenates of guinea-pig urinary bladder, parotid gland, heart and cerebral cortex. [1] Desfesoterodine has a similar pharmacological profile with tolterodine. [2] Intravenous infusion of Desfesoterodine produces a dose-dependent inhibition of the intravesical volume-induced urinary bladder contraction measured as the micturition pressure. [3]
In vivo
Desfesoterodine is significantly more potent at inhibiting acetylcholine-induced urinary bladder contraction than electrically induced salivation in the anaesthetised cat (ID50 15 and 40 nmol/kg, respectively. Desfesoterodine is three times more potent at the urinary bladder compared to the salivary gland. [1]
AliasPNU-200577, 5-hydroxymethyl Tolterodine, 5-HMT, 5-HM, (R)-5-Hydroxymethyl Tolterodine
Chemical Properties
Molecular Weight341.49
FormulaC22H31NO2
Cas No.207679-81-0
SmilesCC(C)N(CC[C@H](c1ccccc1)c1cc(CO)ccc1O)C(C)C
Relative Density.1.060 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
Ethanol: 63 mg/mL (184.5 mM)
DMSO: 65 mg/mL (190.34 mM), Sonication is recommended.
H2O: < 1 mg/mL (insoluble or slightly soluble)
Solution Preparation Table
Ethanol/DMSO
1mg5mg10mg50mg
1 mM2.9283 mL14.6417 mL29.2834 mL146.4172 mL
5 mM0.5857 mL2.9283 mL5.8567 mL29.2834 mL
10 mM0.2928 mL1.4642 mL2.9283 mL14.6417 mL
20 mM0.1464 mL0.7321 mL1.4642 mL7.3209 mL
50 mM0.0586 mL0.2928 mL0.5857 mL2.9283 mL
100 mM0.0293 mL0.1464 mL0.2928 mL1.4642 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Desfesoterodine | purchase Desfesoterodine | Desfesoterodine cost | order Desfesoterodine | Desfesoterodine chemical structure | Desfesoterodine in vivo | Desfesoterodine in vitro | Desfesoterodine formula | Desfesoterodine molecular weight